Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Chinese Journal of Biochemistry and Molecular Biology ; (12): 450-453, 2006.
Article in Chinese | WPRIM | ID: wpr-408644

ABSTRACT

cholesterol 7α-hydroxylase gene ( CYP7A 1 ) plays a key role in the catabolism of cholesterol into bile acids. To investigate whether the A-204C polymorphism in CYP7A1 gene affects the gene expression,using luciferase as the reporter gene, four recombinants were constructed by inserting forward or reverse sequence with A or C allele at the polymorphism site into the promoter-less vector pGL3-basic. The constructs were then transfected into four cell lines and the luciferase activity of each expression vector was examined by dual luciferase reporter gene assay system. The results showed that activities of the forward sequence of both genotypes were higher than that of reverse sequence. Promoter activity of the recombinants with A allele was about one third lower than that with C allele. According to the analysis with TRANSFAC database, there may exist a Zic3 binding site when there is the C allele at -204. Our study indicates that the A-204 C polymorphism in CYP7A1 promoter region decreases its promoter activity and thus represses the gene expression, possibly due to the lack of a potential Zic3 binding site.

2.
Chinese Journal of Medical Genetics ; (6): 444-447, 2004.
Article in Chinese | WPRIM | ID: wpr-328854

ABSTRACT

<p><b>OBJECTIVE</b>To analyze the pattern and prevalence of partial copy deletion of deleted-in-azoospermia (DAZ) gene in the azoospermia factor C(AZFc) region of patients with idiopathic azoospermia or severe oligozoospermia.</p><p><b>METHODS</b>sY581 and sY587 in DAZ gene region were analyzed by polymerase chain reaction-restriction length polymorphism(PCR-RFLP) for its deletion in 197 patients with azoospermia, 166 patients with severe oligozoospermia, and 210 fertile men as controls.</p><p><b>RESULTS</b>Deletion of both DAZ1 and DAZ2 was detected in 18 patients with azoospermia and 10 with severe oligozoospermia, and the prevalence was 9.1% and 6.0% respectively. There was significant difference in deletion rate between the cases and controls.</p><p><b>CONCLUSION</b>The frequency of partial copy deletion of DAZ gene in Chinese idiopathic azoospermia or severe oligozoospermia patients is much higher than that of fertile controls, suggesting that the deletion of DAZ1/DAZ2 may be one of the important genetic etiological factors of spermatogenesis damage. The pattern and prevalence of DAZ partial copy deletion are similar to those of Caucasians populations, and detection of DAZ gene partial copy deletion by PCR-RFLP may be adopted as an additional clinical gene diagnostic measure after AZF microdeletion detection.</p>


Subject(s)
Humans , Male , Azoospermia , Genetics , Chromosomes, Human, Y , Genetics , Deleted in Azoospermia 1 Protein , Gene Deletion , Infertility, Male , Genetics , Models, Genetic , Polymerase Chain Reaction , RNA-Binding Proteins , Genetics
3.
Chinese Medical Journal ; (24): 677-680, 2002.
Article in English | WPRIM | ID: wpr-302229

ABSTRACT

<p><b>OBJECTIVE</b>To investigate polymorphisms in the gene for lipoprotein lipase (LPL) in Chinese populations with coronary heart disease (CHD) and to inquire into the relationship between these polymorphisms in LPL gene and CHD.</p><p><b>METHODS</b>Genomic DNA was extracted from patients with CHD and normal control subjects using a salting out method. The entire coding region and flanking sequences of all coding exons of the LPL gene were amplified by PCR technique and PCR products were detected by denaturing high-performance liquid chromatography (DHPLC) and sequenced with a dideoxy terminal termination method.</p><p><b>RESULTS</b>A novel polymorphic site, G830A, that is within the fifth exon of the LPL gene was found. The 192 codon CGA was changed into CAA and resulted in the substitution of glutamine for arginine. Between the control and CHD groups, chi-square test showed no significant difference in the frequencies of the A/A genotype and A allele (P > 0.05). However, the frequencies of A/A genotype and A allele (0.653 and 0.786) in CHD patients with high plasma triglyceride/lowed plasma high density lipoprotein cholesterol were higher than those (0.415 and 0.642) in CHD patients without hyperlipidemia (P < 0.05).</p><p><b>CONCLUSION</b>No direct association was found between the LPL Arg192-->Gln substitution polymorphism and CHD, but there is a significant positive correlation between the A/A genotype of the LPL gene and CHD associated with high triglyceride/lowed high density lipoprotein cholesterol. This study may provide new data for exploring the molecular mechanism of CHD.</p>


Subject(s)
Humans , Alleles , Apolipoproteins , Blood , Cholesterol, HDL , Blood , Chromatography, High Pressure Liquid , Methods , Coronary Disease , Blood , Genetics , DNA , Chemistry , Genetics , DNA Mutational Analysis , Gene Frequency , Hypertriglyceridemia , Blood , Genetics , Lipoprotein Lipase , Genetics , Lipoproteins , Blood , Polymorphism, Genetic
4.
China Pharmacy ; (12): 73-74, 2001.
Article in Chinese | WPRIM | ID: wpr-411535

ABSTRACT

OBJECTIVE:To introduce pharmacogenomics and its applications in establishing clinical pharmacotherapeutic schemes.METHODS:Based on the analysis of the related literatures,the development and contents of pharmacogenomics and their relationship with individualized medication were summarized.RESULTS:Pharmacogenomics studies the association between gene polymorphisms and the variance of drug effects.CONCLUSION:Pharmacogenomics provides a theoretical basis for medication with safety,effectiveness and rationality.

SELECTION OF CITATIONS
SEARCH DETAIL